HbA1c measurement

被引：19

作者：

Kilpatrick, ES ^{[1
]}

机构：

[1] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England

来源：

JOURNAL OF CLINICAL PATHOLOGY | 2004年 / 57卷 / 04期

关键词：

D O I：

10.1136/jcp.2003.010918

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：344 / 345

页数：2

共 18 条

[11]

*NAT I CLIN EXC, 2002, N0128 NAT I CLIN EXC

[12] PERSISTENT FETAL HEMOGLOBIN AND FALSELY HIGH GLYCOSYLATED HEMOGLOBIN LEVELS [J].

PAISEY, RB ;

READ, R ;

PALMER, R ;

HARTOG, M .

BRITISH MEDICAL JOURNAL, 1984, 289 (6440) :279-280

[13] Defining the relationship between plasma glucose and HbA1c -: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial [J].

Rohlfing, CL ;

England, JD ;

Wiedmeyer, HM ;

Tennill, A ;

Little, RR ;

Goldstein, DE .

DIABETES CARE, 2002, 25 (02) :275-278

[14] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

SHAMOON, H ;

DUFFY, H ;

FLEISCHER, N ;

ENGEL, S ;

SAENGER, P ;

STRELZYN, M ;

LITWAK, M ;

WYLIEROSETT, J ;

FARKASH, A ;

GEIGER, D ;

ENGEL, H ;

FLEISCHMAN, J ;

POMPI, D ;

GINSBERG, N ;

GLOVER, M ;

BRISMAN, M ;

WALKER, E ;

THOMASHUNIS, A ;

GONZALEZ, J ;

GENUTH, S ;

BROWN, E ;

DAHMS, W ;

PUGSLEY, P ;

MAYER, L ;

KERR, D ;

LANDAU, B ;

SINGERMAN, L ;

RICE, T ;

NOVAK, M ;

SMITHBREWER, S ;

MCCONNELL, J ;

DROTAR, D ;

WOODS, D ;

KATIRGI, B ;

LITVENE, M ;

BROWN, C ;

LUSK, M ;

CAMPBELL, R ;

LACKAYE, M ;

RICHARDSON, M ;

LEVY, B ;

CHANG, S ;

HEINHEINEMANN, M ;

BARRON, S ;

ASTOR, L ;

LEBECK, D ;

BRILLON, D ;

DIAMOND, B ;

VASILASDWOSKIN, A ;

LAURENZI, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986

[15] Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study [J].

Stratton, IM ;

Adler, AI ;

Neil, HAW ;

Matthews, DR ;

Manley, SE ;

Cull, CA ;

Hadden, D ;

Turner, RC ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :405-412

[16] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

[17]

WEYKAMP CW, 1993, CLIN CHEM, V39, P138

[18] UNEXPLAINED VARIABILITY OF GLYCATED HEMOGLOBIN IN NONDIABETIC SUBJECTS NOT RELATED TO GLYCEMIA [J].

YUDKIN, JS ;

FORREST, RD ;

JACKSON, CA ;

RYLE, AJ ;

DAVIE, S ;

GOULD, BJ .

DIABETOLOGIA, 1990, 33 (04) :208-215

← 1 2 →